Skip to main content
Signal8

Agarwala Vineeta

SEC insider (Form 3/4/5 filer). CIK 0002003663. Director at Braveheart Bio, Inc. (BRVE) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in SAN FRANCISCO, CA.

Companies Agarwala Vineeta has filed insider reports for

  • Braveheart Bio, Inc. (BRVE): Director
  • TENET HEALTHCARE CORP (THC): Director
Agarwala Vineeta profile photo

Agarwala Vineeta

CIK: 0002003663

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (50.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Braveheart Bio, Inc. logo
BRVE

Braveheart Bio, Inc.

Director
TENET HEALTHCARE CORP logo
THC

TENET HEALTHCARE CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • TENET HEALTHCARE CORP logo
    THC

    TENET HEALTHCARE CORP

    May 27, 2026
    Award

    2026 May Restricted Stock Units

    Direct
    1.2K shares-
  • TENET HEALTHCARE CORP logo
    THC

    TENET HEALTHCARE CORP

    May 22, 2026
    Exercise
    Direct
    1.3K shares-
  • TENET HEALTHCARE CORP logo
    THC

    TENET HEALTHCARE CORP

    May 23, 2025
    Exercise
    Direct
    1.6K shares-
  • TENET HEALTHCARE CORP logo
    THC

    TENET HEALTHCARE CORP

    May 22, 2025
    Award

    Restricted Stock Units

    Direct
    1.3K shares-

1-4 of 4